NORGESTIMATE

SynDRA canonical compound SYN0023284 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ESR1 \| PGR
Mechanism of action	progesterone receptor agonist
Indication	contraceptive
Disease area	endocrinology

All known targets

norgestrel oxime acetate
dexnorgestrel acetime
Norgestimato
Dexnorgestrel acetime
NSC-759159
ORF-10131
RWJ-10131
Norgestimate component of ortho tri-cyclen
Norgestimate component of prefest
Norgestimate component of previfem
Norgestimate component of sprintec
Norgestimate component of tri lo sprintec
Norgestimate component of tri-previfem
Norgestimate component of tri-sprintec
Norgestimatum
Norgestrel oxime acetate
D 138
Norgestimato [INN-Spanish]
Norgestimatum [INN-Latin]
Ortho-Prefest
Norgestimate (USP/INN)
Norgestimate [USAN:INN:BAN]
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-oneoxime
D-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate
NKX8DN6TY9
DTXCID9026922
CHEBI:50815
D-138
C291HFX4DY
RefChem:927916
anti-Norgestimate
Norgestimate, E-
UNII-NKX8DN6TY9